|
|
||||||||
The Journal of Immunology, Vol 156, Issue 3 1030-1037, Copyright © 1996 by American Association of Immunologists
ARTICLES |
RR Dickason, MM Huston and DP Huston
Department of Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
IL-5 is an interdigitating homodimeric glycoprotein and a member of the helical bundle family of cytokines. IL-5 is a potent activator of eosinophils and a specific promoter of their differentiation. This activity has implicated IL-5 in the pathogenesis of asthma and allergic disease. A detailed understanding of IL-5 structure and function is required to develop immunomodulators of IL-5-mediated inflammatory responses. We generated a panel of neutralizing anti-IL-5 mAbs which were used to map functional domains on IL-5. In addition, the nucleotide sequences for human IL-5, murine IL-5, rat IL-5, and eight human/murine IL-5 chimeras were engineered and expressed in COS-7 cells. These recombinant cytokines and mAbs were used in TF-1 bioassays to identify five functional epitopes on the tertiary structure of IL-5. Residues responsible for the species-specific activity of human IL-5 were identified with the murine BCL1 bioassay. One set of epitopes cluster around the helix A-loop 2 region, which is predicted to engage the IL-5 receptor beta-chain. The second set of epitopes as well as the species specificity domain cluster around the loop 3-helix D region, which is predicted to engage the IL-5 receptor alpha-chain. Together, these analyses target the A/D helical face of IL-5 as the region involved in receptor engagement.
This article has been cited by other articles:
![]() |
J. Zhang, R. Kuvelkar, N. J. Murgolo, S. S. Taremi, C.-C. Chou, P. Wang, M. M. Billah, and R. W. Egan Mapping and characterization of the epitope(s) of Sch 55700, a humanized mAb, that inhibits human IL-5 Int. Immunol., December 1, 1999; 11(12): 1935 - 1944. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |